Jump to:
At-a-glance summary of NICE guidance for NIDDM treatment. Adapted from NICE Short Clinical Guideline 87 (May 2009) - Type 2 Diabetes: Newer agents for blood glucose control in type 2 diabetes [partial update of guideline 66].
To view the chart above, you require Flash.
To print: right-click (Windows) or ctrl + click (Macintosh) on the chart and select 'Print...' from the menu.
KEYWORDS: DPP4 inhibitor | Exenatide | Glitazones | Insulin secretagogues | Metformin | Monitoring | Prandial glucose regulator | Rosiglitazone | Saxagliptin | Sitagliptin | Sulfonylureas
This activity will explore the latest data on the SGLT-2 inhibitors and implications for practice. Click here.
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
Supplied by the National
Travel Health Network
and Centre (NaTHNaC)
© Haymarket Media Group Ltd.
